Results 211 to 220 of about 68,768 (336)

The TRIP database showed most Acute Respiratory Infections questions were already addressed by Cochrane reviews [PDF]

, 2019
Brassey, Jon, Carter, Matt, Clark, Justin, Del Mar, Chris, Scott, Anna Mae   +4 more
core   +1 more source

Effectiveness of the antihistamine and anti-PAF effects of rupatadine in allergic diseases: off-label use in a case series study. [PDF]

Drugs Context
Aguiar R, Albores-Arguijo RC, Cichocka-Jarosz E, Jerzynska J, Mack DP.   +4 more
europepmc   +1 more source

Epicutaneous and Drug Provocation Testing in Severe Cutaneous Adverse Reactions: A 20‐Year Single‐Centre Experience

Contact Dermatitis, EarlyView.
This study provides reassuring evidence in favour of early skin testing in patients with SCARs, argues against the necessity of a 6‐month delay, and underscores the pivotal role of oral provocation tests in the safe reintroduction of essential therapies. ABSTRACT Background Identifying and discontinuing the offending drug(s) in severe cutaneous adverse
Zohra Chadli, Khadija Mansour, Ghada Jaouahdou, Manel Ben Belgacem, Yosra Soua, Nadia Ben Fredj, Jameleddine Zili, Haifa Ben Romdhane, Karim Aouam   +8 more
wiley   +1 more source

Medical Melody [PDF]

, 1956
Catholic Physicians\u27 Guilds
core   +1 more source

Antihistamine use in children

Archives of Disease in Childhood: Education & Practice Edition, 2014
Roisin Fitzsimons, L. van der Poel, W. Thornhill, G. du Toit, N. Shah, H. Brough   +5 more
semanticscholar   +1 more source

Repurposing the antihistamine cyproheptadine for osteoarthritis: nothing to sneeze at. [PDF]

J Clin Invest
Loeser RF, Coryell PR.
europepmc   +1 more source

Antihistamines

, 2016
Katsambas, A.D., Goula, M.
  +5 more sources

Cyclizine Toxicity and Misuse in an Adolescent With Eating Disorder and Depression: A Case Report. [PDF]

Cureus
Abdelkhalk AGM.
europepmc   +1 more source

Perceived Acquired Resistance to Omalizumab in Obese Patients With Chronic Spontaneous Urticaria

Clinical &Experimental Allergy, EarlyView.
Francisco Martins, Ilaria Trave, Sofia Pereira, Margarida Gonçalo   +3 more
wiley   +1 more source

Bispecific Dual‐Immune Checkpoint Inhibitor Associated Cutaneous Toxicity: A Report of Lorigerlimab Adverse Skin Reaction in Two Cancer Patients

Journal of Cutaneous Pathology, EarlyView.
ABSTRACT Lorigerlimab is a dual bispecific antibody (BsAb) targeting cytotoxic T‐lymphocyte‐associated protein 4 and programmed cell death protein 1 that is used for treatment of advanced solid cancers such as metastatic castration‐resistant prostate carcinoma.
Niloofar Sina, Fiorinda Muhaj, Volha Lenskaya, Doina Ivan, Victor G. Prieto, Jonathan L. Curry   +5 more
wiley   +1 more source